Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and Asia. The aim of this clinical trial is to compare two
recombinant factor VIII drugs, turoctocog alfa (recombinant factor VIII (N8)) with Advate®,
in haemophilia A subjects, investigating the action and safety of the drugs.